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In this Essay, we argue that pluripotent epiblast founder cells in the embryo and embryonic stem 
(ES) cells in culture represent the ground state for a mammalian cell, signified by freedom from 
developmental specification or epigenetic restriction and capacity for autonomous self-replication. 
We speculate that cell-to-cell variation may be integral to the ES cell condition, safe-guarding 
self-renewal while continually presenting opportunities for lineage specification.Introduction
Mouse embryonic stem (ES) cells are 
permanent cell lines derived from the 
transient founder tissue in the preim-
plantation embryo, the epiblast (see 
Review by C.E. Murry and G. Keller and 
Essay by J. Rossant in this issue of 
Cell). ES cells have three defining prop-
erties: self-renewal, pluripotency, and 
primary chimera formation. After pro-
longed expansion in culture, they retain 
full responsiveness to developmental 
cues and show no intrinsic bias in the 
generation of different somatic lineages 
or germline cells upon reintroduction to 
the embryo. Similar self-renewing cells 
with broad developmental potency can 
also be generated by respecifying germ 
cells with extrinsic factors (Matsui et al., 
1992) or reprogramming somatic cells 
using gene transfection (Takahashi and 
Yamanaka, 2006; see Review by R. Jae-
nisch and R. Young in this issue). Eluci-
dating how cells with such capacities are 
established and propagated is a fasci-
nating scientific challenge, charged with 
biomedical potential.
Considerable evidence indicates that 
a “trinity” of nuclear regulators, Oct4, 
Sox2, and Nanog, governs pluripotency 
in vivo and in vitro (Chambers and Smith, 
2004; Niwa, 2007). Yet Oct4 and Sox2 
also direct production of a destabilizing 
signal, fibroblast growth factor 4 (FGF4), 
which drives ES cells toward differen-
tiation. Neutralizing this autoinductive 
pathway can preserve an uncommitted 
ground state, and we propose that this 
may be the key to capture of authen-
tic ES cells from mammalian embryos 
or by reprogramming. However, recent 
evidence has also established that ES 532 Cell 132, February 22, 2008 ©2008 Elsecells are not homogeneous. Individual 
ES cells exhibit variable expression of 
key factors such as Nanog, have distinct 
probabilities of self-renewal, and may 
have differing developmental potential. 
Moreover, ES cells appear subject to 
promiscuous and fluctuating transcrip-
tion of lineage-affiliated genes. Delineat-
ing cellular transitions and hierarchies 
within the ES cell system should provide 
new insights into the fundamental nature 
of pluripotency and illuminate the incom-
plete capacities often observed in stem 
cells derived from human embryos and 
induced pluripotent stem (iPS) cells gen-
erated by reprogramming.
Transcription Factors Rule  
Pluripotency
Is the pluripotent condition a tabula rasa 
of unrestricted opportunity, or is differen-
tiation prefigured by epigenetic encod-
ing at specifier genes? Heritable modi-
fication of chromatin or DNA leading to 
fixation of gene expression programs is 
a key component in demarcating poten-
tial during development. The epigenetic 
signature of ES cells is characterized by 
coexistence of both activating and silenc-
ing chromatin modifications at multiple 
loci. It is posited that this bivalent status 
may be integral to pluripotency by pro-
viding a mechanism for repressing gene 
expression without permanent silencing. 
However, it is now apparent that bivalent 
domains are not exclusive to pluripotent 
cells (Mikkelsen et al., 2007). Moreover, 
ES cells remain undifferentiated in the 
complete absence of the repressive 
modification (trimethylation of histone 3 
lysine 27) reported in bivalent domains, 
regardless of marginally increased vier Inc.expression of various lineage-affiliated 
genes (Schoeftner et al., 2006). Fur-
thermore, ES cells can withstand dele-
tion of DNA methyltransferases (Dnmts) 
and complete loss of DNA methylation 
without compromising self-renewal or 
genomic integrity, in marked contrast 
to the growth impairment and chromo-
somal abnormalities observed in other 
cell types (Tsumura et al., 2006). In 
general, absence of epigenetic compo-
nents does not ablate the epiblast in the 
embryo or ES cell self-renewal in culture, 
indicating minimal dependency on such 
machinery for generation and mainte-
nance of pluripotent populations (Niwa, 
2007). In fact, early epiblast cells and ES 
cells are characterized by the erasure of 
a major epigenetic feature, the inactive X 
chromosome in female cells (Mak et al., 
2004; Okamoto et al., 2004). Reactivation 
of the silent X coincides with the acqui-
sition of full pluripotency in the nascent 
epiblast reflecting that this is a state cre-
ated by removal rather than imposition of 
epigenetic restrictions.
However, perturbation of the chroma-
tin-modifying machinery and DNA meth-
ylation often result in cell death during 
differentiation, indicating critical roles in 
the faithful prosecution of lineage com-
mitment. It may be argued that cells that 
are blocked in differentiation have lost 
pluripotency. Consider, however, a deter-
mination gene such as MyoD. Mutation 
of MyoD will impair myogenic differentia-
tion, but this does not imply any role for 
MyoD in pluripotency. For genes that act 
in the process of lineage commitment 
this distinction is often blurred. A critical 
test is whether repair of a gene defect is 
sufficient to restore differentiation capa-
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bility. For example, ES cells 
in which the NuRD repres-
sor complex is inactivated by 
deletion of the Mbd3 subunit 
are compromised in prose-
cuting differentiation, but this 
defect is eliminated upon re-
expression of Mbd3, meaning 
that the pluripotent state has 
been preserved throughout 
(Kaji et al., 2006). A specific 
requirement in maintaining the 
pluripotent state should only 
be claimed when a change 
in developmental potential is 
irreversible, as for example 
when Oct4 or Sox2 is deleted 
(Niwa, 2007). Interestingly, 
Mbd3 appears necessary for 
derivation of ES cells, but this 
is because in its absence the 
epiblast does not form prop-
erly (Kaji et al., 2007) and not 
because Mbd3 is required 
by ES cells. In our view, cur-
rent evidence suggests that 
although epigenetic mechanisms of 
gene marking and gene silencing might 
contribute in some degree to the overall 
stability of pluripotency, they are slaves 
not masters in this estate.
In contrast, much evidence indi-
cates that naive pluripotency of early 
epiblast and authentic ES cells is criti-
cally dependent on the action of three 
transcriptional organizers, Oct4, Sox2, 
and Nanog (Chambers and Smith, 2004; 
Niwa, 2007). Coregulatory and auto-
regulatory mechanisms appear to link 
the three factors in a recursive self-re-
inforcing circuit. Each factor is essen-
tial for pluripotent epiblast cells in the 
blastocyst, whereas deletions from ES 
cells provoke unscheduled differentia-
tion into trophoblast and hypoblast cells 
(reviewed in Niwa, 2007). Those fate 
choices are considered developmen-
tally illegitimate because epiblast cells 
have passed beyond their segregation 
points prior to ES cell establishment (see 
Essay by J. Rossant). A key role of the 
trinity of transcription factors appears 
to be to suppress extraembryonic fate 
options through ongoing repression 
of trophoblast and hypoblast specifier 
genes, Cdx2/Eomes and Gata-4/Gata-6, 
respectively (Niwa, 2007). The pluripotent 
condition may thus be viewed as a tran-
scription factor battlefield in which Oct4, 
Sox2, and Nanog are dominant and con-
tinuously suppress functional expres-
sion and activity of lineage specification 
factors (Niwa, 2007; Smith, 2005)
Autoinduced Erk Signaling  
Destabilizes Self-Renewal
Crucially, however, Oct4 and Sox2 also 
provide for developmental extinction of 
pluripotency by directing expression of 
FGF4. This acts as an autoinductive stim-
ulus that propels ES cells toward lineage 
specification (Kunath et al., 2007) (Fig-
ure 1A). Importantly the FGF4/Erk signal 
does not specify lineage but renders ES 
cells responsive to further inductive sig-
nals. Consequently, ES cells or epiblast 
lacking FGF4 or deficient in downstream 
mitogen-activated protein kinase Erk1/2 
signaling exhibit a general impairment of 
commitment.
Recently, a second class of embryo-
derived multipotent stem cells has been 
described that actually depends on FGF 
signaling for propagation (see Essay by 
J. Rossant). ES cells are derived from 
mouse embryos prior to implantation 
into the uterus. After implantation, the 
epiblast undergoes dramatic expansion 
and morphogenesis, transforming from 
an unstructured cell mass into a colum-
nar epithelium. The epithe-
lialized epiblast (cylindrical 
in rodents, discoid in other 
mammals) is subject to potent 
lineage-specifying signals 
from adjacent extraembry-
onic tissues. Cultures of egg 
cylinder stage epiblast in the 
presence of FGF and activin 
give rise to continuous cell 
lines termed EpiSCs (Brons et 
al., 2007; Tesar et al., 2007). 
Unlike ES cells, EpiSCs show 
little or no capacity to colo-
nize developing embryos 
when introduced into blasto-
cysts. They do form multidif-
ferentiated teratomas when 
injected into adult mice, how-
ever, demonstrating a degree 
of multilineage differentiation. 
It will be instructive to deter-
mine the relationship between 
EpiSCs and the FGF4-in-
duced intermediate stage in 
ES cell lineage commitment. 
EpiSCs have culture requirements and 
properties distinct from mouse ES cells 
and similar to those stem cells derived 
to date from human embryos (Brons et 
al., 2007; Tesar et al., 2007). Notably 
their propagation in culture is stimulated 
by FGF. Human embryo cell lines vary in 
their efficiency of differentiation into par-
ticular lineages, perhaps indicating that 
they are partially specified. It could be 
informative to examine whether rodent 
EpiSCs exhibit lineage bias during in 
vitro differentiation and whether this may 
correlate with their original regionaliza-
tion in the egg cylinder. If stem cells can 
be isolated and classified that are pre-
specified for individual germ layers this 
could be advantageous for therapeutic 
applications and drug screening, which 
require the generation of homogeneous 
cell lineages. This is because for ES cells 
it remains a major challenge to steer 
unidirectional commitment. Indeed, 
complete command of this primary fate 
choice may even be incompatible with 
the underlying nature of the pluripo-
tent ground state (see below). A note of 
caution, however, comes from reports 
that both human embryo-derived stem 
cells and rodent EpiSCs differentiate 
into extraembryonic trophoblast with-
out genetic manipulation (see Essay by 
Figure 1. Maintaining Pluripotency
Autoinductive FGF4/Erk signaling poises embryonic stem (ES) cells for lin-
eage entry and must be resisted to allow self-renewal.
(A) Oct4 and Sox2 direct expression of fgf4 and poise ES cells for lineage 
commitment. Elevated Erk activity provides a signal that renders pluripotent 
cells susceptible to lineage inductive cues.
(B) Self-renewal of the pluripotent ES cell state requires overcoming the FGF4/
Erk signal. The actions of FGF can be (1) blocked by selective pharmacological 
inhibitors of the FGF receptor (FGFR) and of Mek; (2) reversed by constitutive 
expression of Nanog; (3) counteracted by blockade of commitment effectors by 
the cytokine leukemia inhibitory factor (LIF) and the morphogen BMP4.
J. Rossant). This is difficult to reconcile 
with the argument that they are authen-
tic representatives of postimplantation 
epiblast and may indicate that they are a 
corrupted state produced in vitro.
Perpetuating naive undifferentiated 
ES cells requires overcoming normal 
developmental progression engendered 
by the accumulating FGF4 signal down-
stream of Oct4 and Sox2. In fact, ES 
cells can be maintained by various in 
vitro artifices (Figure 1B). Conventional 
culture has relied on extrinsic stimula-
tion of the Stat3 transcription factor by 
the cytokine leukemia inhibitory factor 
(LIF) and parallel induction of inhibitor 
of differentiation (ID) proteins by serum 
factors or bone morphogenetic proteins 
(BMPs) (Ying et al., 2003). These signals 
primarily act downstream of Erk signal-
ing to block commitment instructions, 
although LIF/Stat3 also promotes ES cell 
growth and viability. Induction of IDs is 
entirely dispensable if FGF/Erk signaling 
is reduced. Furthermore, genetic disrup-
tion or pharmacological inhibition of the 
FGF4/Erk axis permits self-renewal with-
out engagement of Stat3 (Q.L. Ying, J. 
Wray, J. Nichols, and A.S., unpublished 
data). Therefore, self-renewal appears 
to be the uninstructed or passive fate 
choice for ES cells. However, growth and 
viability are impaired under these condi-
tions, either as a direct consequence of 
loss of Erk activity or possibly due to off-
target effects of the chemical inhibitors. 
This collateral damage can be avoided by 
selective inhibition of glycogen synthase 
kinase-3 (GSK3). Stabilization of intrac-
ellular β-catenin seems to be a contribu-
tory factor downstream of GSK3 inhibi-
tion, either by simulating canonical Wnt 
signaling or by other interactions (Anton 
et al., 2007). Indeed, Wnt3a reinforces 
the suppression of neural commitment 
and may increase the probability of a 
self-renewal division. However, Wnt has 
only minor effects on ES cell growth and 
viability and does not fully reproduce the 
effects of GSK3 inhibition. We hypothe-
size that reduced GSK3 activity restores 
cellular growth and viability, principally 
via global derepression of biosynthetic 
capacity.
The biosynthetic capacity or “energy 
level” of the ES cell, counterregulated 
by GSK3 and Erk, might also directly 
influence the probability of self-renewal 534 Cell 132, February 22, 2008 ©2008 Elseversus commitment. This possibility is 
suggested by quantitative analyses of 
MAPK regulation of the mating type 
switch in yeast. Modeling of these data 
reveals a feedback system whereby the 
threshold for a fate switch is reduced 
in relation to biosynthetic capacity of 
the cell (Colman-Lerner et al., 2005). 
An analogous inverse correlation in ES 
cells could create a situation whereby 
inhibition of Erk both directly sup-
presses effectors that mediate com-
mitment but also indirectly lowers the 
level of effectors required. In this sce-
nario, restoration of the biosynthetic 
capacity by GSK3 inhibition restores 
the threshold for commitment.
The Ground State
ES cells seem to exhibit a unique degree 
of autonomy for a mammalian cell. They 
are intrinsically self-sufficient, unpro-
grammed, and self-replicating, perhaps 
more akin to yeast than other metazoan 
cells. This likely underlies their propensity 
to give rise to multidifferentiated tumors 
known as teratocarcinomas (Chambers 
and Smith, 2004).
The question arises of whether ES 
cells are a tissue culture epiphenom-
enon, as has often been suggested, 
or whether early epiblast cells are in 
an equivalent state? The epiblast is 
generated from bifurcation of the pri-
mary inner cell mass (ICM) in the blas-
tocyst. Inhibition of Erk signaling in 
early embryos suppresses emergence 
of hypoblast cells and results in devel-
opment of the entire ICM into epiblast 
(Chazaud et al., 2006; J. Nichols, 
J.S., and A.G.S., unpublished data). 
Augmented by inhibition of GSK3 the 
nascent epiblast expands in situ under 
these conditions and if explanted gives 
rise to ES cells. Early epiblast cells are 
thus comparable to ES cells in their 
independence from but vulnerability to 
Erk signaling. Epiblast cells also give 
rise to teratocarcinomas if displaced 
from the powerful inductive environ-
ment of the early embryo (Stevens, 
1983). ES cells may therefore be true 
counterparts of naive epiblast rather 
than culture creations. If epiblast and 
ES cell pluripotency are founded on a 
common ground state, this would be 
expected to be conserved in essential 
features between mammalian species. vier Inc.A testable prediction is that it should 
be possible to capture authentic ES 
cells from epiblasts of other species by 
targeting the Erk and GSK3 pathways.
Is the ground state hypothesis rel-
evant to reprogramming? It is striking 
that in vitro the differentiated epig-
enome can be “collapsed” (that is, 
the restrictive epigenetic program of 
somatic cells can be deconstructed 
and erased) to recreate pluripotency. 
However, iPS cells produced by direct 
reprogramming (using a four-factor 
cocktail comprising Oct4, Sox2, cMyc, 
and Klf4) often exhibit compromised 
gene expression profiles, epigenetic 
features, and developmental poten-
tial compared with authentic ES cells 
(Takahashi and Yamanaka, 2006). This 
may be due to incomplete deprogram-
ming creating an aberrant pheno-
type, or to precipitous transit through 
the ES cell state and conversion to a 
downstream cell such as an EpiSC. 
Intriguingly, the transcription factor 
Rex1 appears to be expressed at low 
or negligible levels in some iPS cells 
(Okita et al., 2007) and is also down-
regulated in EpiSCs. We suggest that 
creation of iPS cells is likely to entail 
a process of epigenetic deconstruction 
that reaches, and is stable in, the true 
ground state only if and when (1) Nanog 
is activated; (2) appropriate stoichiom-
etry of the endogenous trinity factors is 
established: (3) extrinsic perturbations 
are minimized. A prediction is that inhi-
bition of Mek and GSK3 should facili-
tate isolation of fully deprogrammed 
iPS cells by consolidating the ground 
state and eliminating EpiSCs and other 
phenotypes that cannot expand in 
these minimal conditions.
ES Cells: A Heterogeneous Coalition
Forced constitutive expression of Nanog 
is sufficient to prevent ES cell differentia-
tion and render self-renewal constitutive 
even in the presence of active FGF/Erk 
signaling (Chambers et al., 2003; Ying et 
al., 2003). This implies that Nanog is nor-
mally limiting in ES cell cultures and that 
the Oct4/Sox2/Nanog trio of transcrip-
tion factors is subject to a component 
of negative regulation. In fact, expres-
sion levels of Nanog are highly variable 
in ES cells (Figure 2A), contrasting with 
the apparent homogeneity of Oct4 and 
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Sox2. Furthermore, ES cells in which 
both alleles of Nanog have been deleted 
can remain undifferentiated and pluripo-
tent (Chambers et al., 2007). Other pluri-
potency genes and many putative targets 
of Nanog identified by genome location 
analyses continue to be expressed in 
ES cells lacking Nanog. These findings 
challenge the dogma that Nanog acts 
in partnership with Oct4 and Sox2 in 
housekeeping transcriptional mainte-
nance of pluripotency. However, cells 
lacking Nanog, whether by endogenous 
downregulation or gene deletion, do have 
a greatly increased tendency to differen-
tiate (Chambers et al., 2007; Mitsui et al., 
2003). This suggests that Nanog plays a 
pivotal role in buffering ES cells against 
the consequences of Erk signaling. In 
vivo deletion and cell fusion studies have 
demonstrated that Nanog functions in 
establishing de novo the unrestricted 
states of pluripotency (Mitsui et al., 2003; 
Silva et al., 2006) (J. Nichols, J.S., and 
A.S., unpublished data) and of germ 
cells (Chambers et al., 2007). In ES cell 
cultures, therefore, Nanog may reverse 
the effects of Erk signaling or of second-
ary inducers, resetting the ground state. 
Further insight should be obtained by 
examining whether absence of Nanog 
facilitates efficient conversion of ES cells 
into EpiSCs and whether EpiSCs lacking 
Nanog can be maintained or have altered 
developmental competence.
In the embryo, Nanog expression is 
also dynamic as it is downregulated at 
the time of implantation and re-emerges 
in the posterior egg cylinder. Creation of 
a green fluorescent protein (GFP) allele 
has established that mosaic expres-
sion in ES cells is determined primar-
ily at the level of transcription and is 
fully reversible. The underlying mecha-
nism is unknown. One possibility is an 
intrinsic oscillatory circuit mediated by 
autorepression (I. Chambers, personal 
communication). This may operate syn-
chronously over the short time span of 
epiblast development but become asyn-
chronous in expanded ES cell cultures. 
Alternatively, the fluctuations may be 
stochastic, as appears for initial Nanog 
expression in the embryo (Dietrich and 
Hiiragi, 2007). Whatever the mechanism, 
varying levels of Nanog impart functional 
heterogeneity in self-renewal probability 
upon individual ES cells (Chambers et 
al., 2007). Nanog is not the only pluri-
potency gene that exhibits nonuniform 
expression in ES cells. Rex1 (Zfp42) is 
also expressed differentially between 
interconvertible subpopulations with dis-
tinct growth and differentiation proper-
ties (Toyooka et al., 2008). Furthermore, 
ES cells exhibit transcriptional activity 
for many genes associated with lineage 
commitment and differentiation, similar 
to the phenomenon of multilineage prim-
ing (also known as multilineage preview) 
described in hematopoietic stem cells 
(Hu et al., 1997; Ye et al., 2003). This 
promiscuity has been widely exploited 
in promoterless gene trap screens 
(Skarnes et al., 1995). Some of these 
insertions show mosaic reporter profiles 
in undifferentiated ES cells (W. Skarnes, 
personal communication) indicating that 
lineage preview is subject to fluctuation. 
Therefore, the convention that ES cell 
cultures are homogeneous can no longer 
be maintained. Rather, they comprise a 
coalition of transitory transcriptional set-
tings. Can this be reconciled with the 
ground state hypothesis?
A Platform for Multilineage Decisions
The foundation of pluripotency may be 
a fluid transcriptome. In open transcrip-
tional space an uncommitted condition 
may be maintained if incipient gene reg-
ulatory networks are mutually antago-
nistic. This depends on crossinhibition 
restricting the probability of any single 
program attaining an activation threshold 
for dominance over the resident masters, 
Oct4/Sox2/Nanog. Neutralizing conflicts 
between multiple opposing transcription 
factor circuits could create a metastable 
state (Figure 2B). Analogous transcrip-
tion factor duels have been proposed 
to underlie multilineage potential in the 
hematopoietic system (Huang et al., 
2007). Promiscuous transcription may 
set the stage for lineage specification by 
parading the possibilities. For this com-
petent state to be perpetuated, however, 
fluctuations in expression level should 
be constrained or their consequences 
reversed. Conversely, the Erk signal 
should destabilize the ground state 
to promote lineage specification. This 
might be achieved by increasing glob-
ally the amplitude of fluctuations in the 
system. Alternatively, Erk may selectively 
target particular circuits, for example to 
upregulate pathway responsiveness to 
secondary inducers. Whether chromatin 
modification is a direct target of Erk or 
of secondary inductive signals is cur-
rently unknown. In ES cell cultures, Stat3 
and ID proteins may directly antagonize 
effectors downstream of Erk. Nanog acts 
in parallel by unknown mechanisms to 
restrict or undo consolidation of nascent 
transcriptional and epigenetic architec-
ture of lineage specification. Optimal 
self-renewal requires both components, 
although either alone can be sufficient.
Cell-to-cell variation in Nanog levels 
creates graded differences in resis-
tance to differentiation, ranging from 
highly refractory to highly susceptible. 
This heterogeneity likely contributes to 
two well-remarked features of ES cell 
Figure 2. A Metastable Coalition
The transcription factor Nanog secures self-re-
newal of ES cells, and cell-to-cell variation creates 
the possibility for differentiation. (A) Embryonic 
stem (ES) cells are heterogeneous. Immunostain-
ing shows highly variable levels of Nanog protein 
in Oct4-positive undifferentiated ES cells. (B) In 
our model, lineage-associated transcriptional cir-
cuits (A, B, and C) are maintained below threshold 
levels due to mutual antagonism and suppression 
by the three transcription factors Oct4, Sox2, and 
Nanog. A destabilized transitional state arises 
when downregulation of Nanog coincides with 
increased activation of Erk. Phosphorylated Erk 
(pErk) may activate inductive signaling pathways 
or directly promote lineage-affiliated transcrip-
tional networks. The fluctuations in network ac-
tivities generated by pErk confer an opportunity 
to establish a new stable cell state. However, if 
Nanog levels rise before commitment is effected, 
the actions of pErk are neutralized, the metastable 
ground state is restored, and the gate is closed. 
Photo courtesy of J. Silva and A. Smith.
cultures: the incidence of background 
differentiation under conditions favor-
ing self-renewal and the persistence of 
undifferentiated cells under conditions 
favoring differentiation (Smith, 2001). 
The regulation and dynamics of transi-
tions in Nanog expression have yet to 
be fully characterized but do not appear 
related to cell cycle because downregu-
lation of knockin GFP can be sustained 
for more than one round of cell division 
before re-expression (Chambers et al., 
2007). Although it is clear that ES cells 
can move back and forth between high 
and low Nanog expression, it is also 
evident that many ES cells that down-
regulate Nanog then exit self-renewal. 
ES cells that lack Nanog may comprise 
a spectrum of phases between lineage 
specification and commitment.
There may also be significant hetero-
geneity within the Nanog-positive ES 
cell population. One possibility is that ES 
cells may continually spin-off derivatives 
that are in an EpiSC state. The reported 
mosaicism in Rex1 reporter gene expres-
sion might indicate that EpiSCs do coex-
ist with ES cells, at least under some 
culture conditions. EpiSCs are otherwise 
indistinguishable from ES cells using 
the conventional pluripotency markers, 
Oct4, Sox2, and Nanog. They would be 
expected to persist at least transiently in 
coculture with ES cells due to paracrine 
provision of their supporting growth 
factors FGF4 and Nodal. Significantly, 
EpiSCs do not spontaneously convert 
back to ES cells. It is conceivable that 
ES cell cultures are structured hierarchi-
cally with only a portion of cells retaining 
full developmental potential. This would 
be consistent with data suggesting that 
many cells in ES cell cultures may not 
be competent to contribute to chimeras 
(Wang and Jaenisch, 2004). The het-
erogeneities described here (and those 
yet to be discovered) should be consid-
ered when interpreting transcriptomic 
and other global datasets generated 
from bulk ES cell populations. Adapta-
tion of technologies developed in yeast 
(Colman-Lerner et al., 2005; McClean 
et al., 2007) for interrogating, measur-
ing, and modeling cell-to-cell variation is 536 Cell 132, February 22, 2008 ©2008 Elselikely to be crucial for further deconvolu-
tion of the ES cell condition. An interface 
between stem cell research and systems 
biology may now be key to understand-
ing the decision pathways that face ES 
cells poised between pluripotency and 
lineage commitment.
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